Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Essex Bio-Technology Limited (HK:1061)
HKEX:1061
Holding HK:1061?
Track your performance easily
1061 Stock Chart & Stats
Day’s RangeHK$0 - HK$0
52-Week RangeHK$1.96 - HK$3.10
Previous CloseHK$2.8
Volume575.00K
Average Volume (3M)328.75K
Market Cap
HK$1.59B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)6.0
Beta0.59
Next Earnings
Mar 25, 2025EPS EstimateN/A
Last Dividend Ex-Date
Sep 09, 2024Dividend Yield3.89%
Share Statistics
EPS (TTM)0.46
Shares OutstandingN/A
10 Day Avg. Volume248,500
30 Day Avg. Volume328,754
Standard Deviation0.11
R-Squared0.13
Alpha-0.00446
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Essex Bio-Technology News
PremiumCompany Announcements
Essex Bio-Technology Updates Hong Kong Share Registrar
PremiumCompany Announcements
Essex Bio-Tech Expands Ophthalmic Product Line in China
PremiumCompany Announcements
Essex Bio-Tech Announces Mid-Year Dividend
PremiumCompany Announcements
Essex Bio-Technology Reports Mixed H1 2024 Results
PremiumCompany Announcements
Essex Bio-Technology Launches New Eye Drops in China
PremiumCompany Announcements
Essex Bio-Technology Schedules Key Financial Meeting
PremiumCompany Announcements
Essex Bio-Technology Completes Loan RepaymentOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.30% Mutual Funds
― Other Institutional Investors
97.68% Public Companies and
Individual Investors
1061 FAQ
What was Essex Bio-Technology Limited’s price range in the past 12 months?
Essex Bio-Technology Limited lowest stock price was HK$1.96 and its highest was HK$3.10 in the past 12 months.
What is Essex Bio-Technology Limited’s market cap?
Currently, no data Available
When is Essex Bio-Technology Limited’s upcoming earnings report date?
Essex Bio-Technology Limited’s upcoming earnings report date is Mar 25, 2025 which is in 119 days.
How were Essex Bio-Technology Limited’s earnings last quarter?
Essex Bio-Technology Limited released its earnings results on Aug 26, 2024. The company reported HK$0.277 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.277.
Is Essex Bio-Technology Limited overvalued?
According to Wall Street analysts Essex Bio-Technology Limited’s price is currently Overvalued.
Does Essex Bio-Technology Limited pay dividends?
Essex Bio-Technology Limited pays a Annually dividend of HK$0.06 which represents an annual dividend yield of 3.89%. See more information on Essex Bio-Technology Limited dividends here
What is Essex Bio-Technology Limited’s EPS estimate?
Essex Bio-Technology Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Essex Bio-Technology Limited have?
Essex Bio-Technology Limited has 567,360,000 shares outstanding.
What happened to Essex Bio-Technology Limited’s price movement after its last earnings report?
Essex Bio-Technology Limited reported an EPS of HK$0.277 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.433%.
Which hedge fund is a major shareholder of Essex Bio-Technology Limited?
Currently, no hedge funds are holding shares in HK:1061
---
Essex Bio-Technology Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
13.49%
12-Months-Change
Fundamentals
Return on Equity
13.75%
Trailing 12-Months
Asset Growth
4.83%
Trailing 12-Months
Company Description
Essex Bio-Technology Limited
Essex Bio-Technology Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in developing, manufacturing, and selling of biopharmaceutical products. The biopharmaceutical products are developed for the treatment and healing of surface wounds and eye wounds. The company reports in two segments that are Ophthalmic products and Surgical products. It focuses on the Ophthalmology and surgical arena of topical (skin) surface wounds primarily covering dermatology, stomatology, obstetrics, and gynecology. The company's products include Beifushu Eye Drops, Beifushu Gel, Beifuji Spray, Lodized Lecithin Capsule, Medictop, and others. All of the company revenues are generated from the People's republic of china.
---
Technical Analysis
Shanghai Haohai Biological Technology Co., Ltd. Class H
―
ESR Group Limited
―
Ascentage Pharma Group International
―
---